Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
Abstract Background Interstitial lung diseases (ILD) encompass a heterogenous group of diffuse parenchymal lung disorders characterized by variable degrees of inflammation and fibrosis. Pretherapeutic clinical testing models for such diseases can serve as a platform to test and develop effective the...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-03-01
|
| Series: | Respiratory Research |
| Online Access: | https://doi.org/10.1186/s12931-023-02404-7 |